drugset

drugset / Trial / NCT02308033

Multi-Center Study of New Medications to Treat Vaginal Infections

NCT02308033 ↗

Phase 3 Completed 204 enrolled Curatek Pharmaceuticals, LLC

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of metronidazole gel in the treatment of vaginal infections.

Timeline

Start: 2015-06
Primary completion: 2017-06
Completion: 2017-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Metronidazole	Small molecule	—	Other

Indications